Evaxion A (EVAX) Liabilities and Shareholders Equity (2019 - 2026)

Evaxion A (EVAX) posted Liabilities and Shareholders Equity of $23.6 million for Q1 2026, down 16.78% on a QoQ basis from $28.4 million in Q4 2025, and down 6.33% year-over-year from $25.2 million in Q1 2025.

Evaxion A (EVAX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Evaxion A's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $23.6 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 6.33% year-over-year to $23.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.2 million (up 96.84% YoY) and the FY2025 annual result came in at $28.4 million, up 127.54% from the prior year.
  • Liabilities and Shareholders Equity was $23.6 million for Q1 2026 at Evaxion A, down from $28.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $41.1 million in Q1 2022 and bottomed at $22654.0 in Q1 2024.
  • A 5-year average of $21.5 million and a median of $22.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity plunged 99.89% — and 2025, when it jumped 111310.79%.
  • Evaxion A's Liabilities and Shareholders Equity stood at $22.0 million in 2022, then tumbled by 41.48% to $12.9 million in 2023, then decreased by 3.13% to $12.5 million in 2024, then soared by 127.54% to $28.4 million in 2025, then fell by 16.78% to $23.6 million in 2026.
  • Business Quant data shows EVAX's Liabilities and Shareholders Equity at $23.6 million in Q1 2026, $28.4 million in Q4 2025, and $29.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Evaxion A 25.44 Mn 25.44 Mn - 23.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.64 Mn
Dec 31, 2025 28.41 Mn
Sep 30, 2025 29.74 Mn
Jun 30, 2025 22.45 Mn
Mar 31, 2025 25.24 Mn
Dec 31, 2024 12.49 Mn
Jun 30, 2024 15.23 Mn
Mar 31, 2024 22,654.00
Dec 31, 2023 12.89 Mn
Sep 30, 2023 11.94 Mn
Jun 30, 2023 16.75 Mn
Mar 31, 2023 20.49 Mn
Dec 31, 2022 22.03 Mn
Sep 30, 2022 27.45 Mn
Jun 30, 2022 34.00 Mn
Mar 31, 2022 41.08 Mn
Dec 31, 2021 40.16 Mn
Sep 30, 2021 24.12 Mn
Jun 30, 2021 27.66 Mn
Mar 31, 2021 34.92 Mn